Notice: This company has been marked as potentially delisted and may not be actively trading. Synthorx (THOR) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Design Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | seekingalpha.comDesign Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | insidermonkey.comEndeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial OfficerMarch 14, 2024 | finance.yahoo.comEndeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of DirectorsDecember 19, 2023 | finance.yahoo.comBiosimilar Interleukins Global Market Report 2023February 16, 2023 | uk.finance.yahoo.comImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors - Yahoo Finance UKOctober 4, 2022 | uk.finance.yahoo.comCapstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering - Business WireSeptember 14, 2022 | businesswire.comMedikine Initiates First Clinical Trial of its Lead Program, an Interleukin-7 Mimetic, Under Management Team with Expertise in Next-Generation Cytokine Drug Discovery and Development - Business WireJuly 19, 2022 | businesswire.comForm SC 14D9 Turning Point Therapeuti Filed by: Turning Point Therapeutics, Inc. - StreetInsider.comJune 17, 2022 | streetinsider.comVBK: Why Growth Investors Should Avoid The Small-Caps (NYSEARCA:VBK) - Seeking AlphaJune 9, 2022 | seekingalpha.comElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development - Yahoo FinanceJune 2, 2022 | finance.yahoo.comForm DEF 14A Janux Therapeutics, Inc. For: Jun 14 - StreetInsider.comApril 30, 2022 | streetinsider.comU.S. Stocks Pull Back Sharply, Contributing To Nasdaq's Worst Month Since 2008 - NasdaqApril 29, 2022 | nasdaq.comSanofi (SNY) Q1 2022 Earnings Call Transcript - The Motley FoolApril 29, 2022 | fool.comGlobal Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application, By Type, By Regional Outlook and Forecast, 2021 - 2027 - Yahoo FinanceApril 4, 2022 | finance.yahoo.comGennao Bio Strengthens Board of Directors with Appointments of Peter Thompson, MD, and Bradley Campbell - StreetInsider.comMarch 17, 2022 | streetinsider.comImmuno-Oncology Drugs Global Market Report 2022March 8, 2022 | nz.finance.yahoo.comImmuno-Oncology Drugs Global Market Report 2022 - Benzinga - BenzingaMarch 5, 2022 | benzinga.comA $28.8 Billion Global Opportunity for Synthetic Biology by 2026 - New Research from StrategyR - Benzinga - BenzingaMarch 3, 2022 | benzinga.comProtein Inhibitors Global Market Report 2022 - Yahoo FinanceMarch 3, 2022 | finance.yahoo.comA $28.8 Billion Global Opportunity for Synthetic Biology by 2026 - New Research from StrategyR - PR NewswireMarch 3, 2022 | prnewswire.comImmuno-Oncology Drugs Global Market Report 2022 - Yahoo FinanceMarch 3, 2022 | finance.yahoo.comOrbiMed Names Two New General Partners - Business WireDecember 7, 2021 | businesswire.comOrbiMed Names Two New General Partners - StreetInsider.comDecember 7, 2021 | streetinsider.comMedicenna Therapeutics: Treating Cancer With Immunomodulators - Seeking AlphaNovember 13, 2021 | seekingalpha.comNektar: The Anatomy Of A Shakedown - Seeking AlphaNovember 10, 2021 | seekingalpha.comOnchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific OfficerOctober 28, 2021 | finance.yahoo.comOnchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer - StreetInsider.comOctober 26, 2021 | streetinsider.comJoint Pain Injections Market Surpass - US$ 10.3 Bn by 2028 - GlobeNewswireSeptember 30, 2021 | globenewswire.comImmuno-Oncology Drugs Global Market Report 2021 - ResearchAndMarkets.com - Business WireSeptember 29, 2021 | businesswire.comBiosimilar Interleukins Global Market Report 2021: COVID-19 Growth And Change To 2030 - Yahoo FinanceSeptember 27, 2021 | finance.yahoo.comImmuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030September 24, 2021 | uk.finance.yahoo.comNektar And Bristol Myers Squibb Expecting Bempeg Approval - Seeking AlphaSeptember 18, 2021 | seekingalpha.comSanofi (SNY) to Buy Kadmon for $1.9B, Add cGVHD Drug Rezurock - NasdaqSeptember 8, 2021 | nasdaq.comMeet the top young leaders transforming the biotech industrySeptember 8, 2021 | businessinsider.comWill only a handful of companies solve the childcare crisis? - FortuneAugust 24, 2021 | fortune.comAristea Appoints Justin Thacker as Chief Financial Officer - Yahoo FinanceAugust 23, 2021 | yahoo.comAristea Appoints Justin Thacker as Chief Financial Officer - Markets InsiderAugust 23, 2021 | markets.businessinsider.comSanofi SA (SNY) CEO Paul Hudson on Q2 2021 Results - Earnings Call Transcript - Seeking AlphaJuly 29, 2021 | seekingalpha.com Get Synthorx News Delivered to You Automatically Sign up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter. Email Address THOR Media Mentions By Week THOR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THOR News Sentiment▼0.000.86▲Average Medical News Sentiment THOR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THOR Articles This Week▼03▲THOR Articles Average Week Get Synthorx News Delivered to You Automatically Sign up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Teleflex News Today Integer News Today Integra LifeSciences News Today AtriCure News Today Alphatec News Today Orthofix Medical News Today Surmodics News Today AngioDynamics News Today Accuray News Today Rockwell Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:THOR) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump plans $32 billion+ AI “Manhattan Project”Our research indicates ONE AI stock is poised to benefit the most. And even OpenAI founder Sam Altman admit...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthorx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synthorx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
